Noah Goodman
Chief Business Officer · Kymera Therapeutics, Inc.
- 2026
- Jul 2, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Noah Goodman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
- Nello Mainolfi - $36.82M in KYMR purchases and sales in the last 12 months
- Jeremy G. Chadwick - $15.60M in KYMR purchases and sales in the last 12 months
- Bruce N. Jacobs - $9.96M in KYMR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Noah Goodman?
Noah Goodman is a corporate insider, tracked as Chief Business Officer of Kymera Therapeutics, Inc. (KYMR). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Noah Goodman last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 6 filings going back to 2026.
Has Noah Goodman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($2.22M) across all tracked filings.
